Huize Launches Customized Mid-Tier Medical Insurance Product "PrimeMed" in Partnership with CCIC and MSH CHINA

Stock Information for NeuroSense Therapeutics Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NeuroSense Therapeutics Ltd.

Huize Holding Limited to Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025
Huize pioneers DeepSeek integration in China's insurance sector, revolutionizing consumer-facing insurance services for the AI era
Huize Served Over 1.3 Million Families, Facilitating More Than 12 Million Insurance Policies in 2024
Huize Regains Compliance with Nasdaq Minimum Bid Price Requirement
Huize Holding Limited Reports Third Quarter 2024 Unaudited Financial Results
Huize Holding Limited to Report Third Quarter 2024 Financial Results on December 10, 2024
Huize Holding Limited Announces Plan to Implement ADS Ratio Change
Huize's "Chang Xiang An No.2" Long-Term Medical Insurance Product Wins "Annual Popular Commercial Health Insurance Product" Award from Today Insurance

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.